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Summary
Despite its medical, social, and economic significance, under-
standing what primarily causes aging, that is, the mechanisms of
the aging process, remains a fundamental and fascinating
problem in biology. Accumulating evidence indicates that a small
RNA-based gene regulatory machinery, the Piwi-piRNA pathway,
represents a shared feature of nonaging (potentially immortal)
biological systems, including the germline, somatic cancer stem
cells, and certain ‘lower’ eukaryotic organisms like the planarian
flatworm and freshwater hydra. The pathway primarily functions
to repress the activity of mobile genetic elements, also called
transposable elements (TEs) or ‘jumping genes’, which are
capable of moving from one genomic locus to another, thereby
causing insertional mutations. TEs become increasingly active
and multiply in the genomes of somatic cells as the organism
ages. These characteristics of TEs highlight their decisive
mutagenic role in the progressive disintegration of genetic
information, a molecular hallmark associated with aging. Hence,
TE-mediated genomic instability may substantially contribute to
the aging process.
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Intense investigation in aging research has led to the identification of
over five hundred evolutionarily conserved genes, the mutational or RNA
interference-mediated inactivation of which slows down the rate of the
aging process in divergent eukaryotic species (Kenyon, 2010). While
many of these genetic interventions can significantly promote longevity,
they are unable to halt aging. Even mutant animals with extreme
longevity continue to age, albeit at a diminished rate when contrasted
with their corresponding controls, and eventually die. One of the most
striking examples is represented by a gonad-ablated daf-2 mutant
Caenorhabditis elegans strain that is simultaneously defective for
germline activity and insulin/IGF signaling (daf-2 encodes a receptor
tyrosine kinase that is the C. elegans insulin/insulin-like growth factor
receptor ortholog). These nematodes live approximately four times as
long as normal (Arantes-Oliveira et al., 2003). In human terms, this
lifespan extension would correspond to ~350 years. Longevity genes
identified so far thus appear to regulate the rate at which cells age, or
suppress the cause of a pathology limiting lifespan to some extent, but
the exact mechanisms by which they influence lifespan remain largely
unknown. Indeed, understanding what primarily causes aging is still
generally considered a great challenge in biology, with significant
medical, economic, and social implications (Kenyon, 2010; Baudisch &
Vaupel, 2012; Gems & Partridge, 2013; Lopez-Otın et al., 2013).
A related problem in aging research is that of the mortality rate,
which displays an exponential growth throughout the adult life in
numerous animal species, including humans (Baudisch & Vaupel, 2012).
In practical terms, the age of an organism correlates exponentially with
the organism’s risk to acquire a fatal disease and, eventually, to die. As
the accumulation of mutations and harmful metabolic factors, such as
reactive oxygen species, causing cellular damage, in particular, trun-
cated, misfolded, oxidized, and aggregated proteins that interfere with
cellular homeostasis and functions, is known to occur at a nearly
constant rate during the lifespan, the causal role of somatic mutations
and intracellular metabolism in the aging process remains unresolved.
This issue has bred speculations regarding potential genetic or metabolic
components that are likely to be generated exponentially, and to
primarily contribute to aging (Kirkwood & Proctor, 2003; Kirkwood,
2008).
Triggered by unrepaired mutations, genomic instability is a key
feature of aging cells (Lopez-Otın et al., 2013). Nonaging biological
systems however show either no or only limited signs of genome
disintegration. Such potentially immortal systems involve the germline
that genetically interconnects the subsequent generations, somatic
cancer stem cells with indefinite proliferation capacity, and certain
organisms from some ‘lower’ animal taxa (e.g. Planaria and Cnidaria),
somatic cells of which display stem cell-like features (Kyriazis, 2014). The
term of ‘nonaging cells’ refers to cells constituting a tissue that traces an
essentially immortal lineage. Nonaging tissues display an indefinite
renewal capacity. In nonaging cells, genome integrity remains largely
stable during the lifespan. ‘Aging cells’ refer to cells constituting a tissue
that ages—gradually deteriorates—over time. Genomic instability in
aging cells progressively increases during adulthood, thereby limiting
their capacity to proliferate and survive. A molecular machinery primarily
responsible for maintaining the integrity of genetic material is the Piwi-
piRNA (P-element-induced wimpy testis in Drosophila—Piwi-interacting
noncoding RNA) pathway (Aravin et al., 2007). This small RNA-based
gene regulatory system operates predominantly in nonaging cells (Sedivy
et al., 2013; Ross et al., 2014; Sturm et al., 2015). The pathway was
originally discovered in the Drosophila male germline, and established to
function in repressing the activity of mobile genetic elements, also called
transposable elements (TEs) or ‘jumping genes’. It is also active in various
tumorous cell lines (reviewed by Ross et al., 2014), implying that
nonaging somatic cancer stem cells adopt certain germline-specific
characteristics, that is, some extent of soma-to-germline transformation,
including the activity of the Piwi-piRNA pathway and an unlimited
proliferation capacity. In addition, certain planaria and cnidaria, such as
the planarian flatworms and freshwater hydra, respectively, somatically
express components of the Piwi-piRNA pathway, rendering the self-
renewal ability of their somatic cells apparently unlimited (Martinez,
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1998; Petralia et al., 2014). These organisms can reproduce clonally,
that is the progeny can actually ‘regenerate’ from somatic cells of the
parental body. Thus, besides the germline, the Piwi-piRNA pathway is
also active in essentially all types of nonaging somatic cells in diverse
organisms, including somatic stem cells in sponge, jellyfish, planaria (in
this organism, totipotent stem cells are called neoblasts), sea slug, fruit
fly (e.g. in Drosophila, the germline function of Piwi proteins depends on
the somatic cells of the gonad; Cox et al., 1998), sea squirt, and
mammals (reviewed in Ross et al., 2014). In humans, various somatic
cancers and hematopoietic stem cells are known for the activity of the
Piwi-piRNA pathway. These somatic cells/tissues exhibit a largely or
essentially unlimited proliferation/renewal capacity, and the pathway
functions not only in TE silencing but also in various other cellular
processes including epigenetic programming, regeneration, and prolif-
eration. It is intriguing that in the postmitotic organism D. melanogaster
(‘postmitotic’ means that somatic cells no longer proliferate after
completing development), somatic tissues and organs expressing Piwi
proteins, such as the gonad, brain, salivary gland, and fat body, are
prone to form cancer or at least contribute to the reactivation of
dormant self-renewing progenitor—blast—cells (Sousa-Nunes et al.,
2011; Ross et al., 2014; Jones et al., 2016). Piwi proteins in the fly
may thereby also accumulate in somatic stem cells.
TEs are capable of moving from one genomic locus to another,
frequently generating insertional mutations in functional DNA regions
(Malone & Hannon, 2009; Levin & Moran, 2011). These highly
repetitive genetic elements are effectively repressed by the activity of
the Piwi-piRNA pathway in nonaging germline and somatic cells. In
contrast, aging somatic cells, in which the Piwi-piRNA pathway is
inactive, are susceptible to significant levels of transposition. Although
TEs were previously considered inert DNA stretches labeled ‘junk DNA’,
accumulating evidence has revealed that many types of TEs become
increasingly mobile in the genomes of somatic cells as the organism
ages (Kazazian, 2011; Huang et al., 2012). In good accordance with
these findings, the increasing activity of TEs is linked to the incidence
of various age-associated degenerative pathologies (O’Donnell & Burns,
2010; Li et al., 2013; Kreiling et al., 2017). The cumulative mutagenic
effect of TE-derived insertions is likely highly significant, partly because
TEs constitute a significant portion of eukaryotic genomes (for
instance, the human genome contains thousands of copies of active
TEs; Huang et al., 2012), and partly because novel TE insertions
represent a far higher mutagenic load to the cell than mutations
generated by chemical or physical mutagens. TE insertions consist of
normal, chemically unaltered nucleotides, and therefore cannot be
recognized and eliminated by the otherwise effective DNA repair
mechanisms. In eukaryotic genomes, the great majority of TEs belong
to the class of self-duplicating retrotransposons, which are mobilized
via the so-called ‘copy-and-paste’ replication mechanism; the original
TE does not get excised from its donor locus while the novel copy
jumps into a different genomic position. Continuous mobilization of
such elements gradually increases their own copy number over the
adult lifespan (De Cecco et al., 2013a). This may cause an exponential
mutation rate in the genomes of somatic cells as the organism ages
(Sturm et al., 2015). If the mobilization of retrotransposons indeed
displays an exponential rate in aging somatic cells, the growth
dynamics of their copy number could correlate to the mortality
pattern of many animal species (Fig. 1).
In aging somatic cells, the Piwi-piRNA pathway is largely inactive. Its
TE-inhibiting function can be somewhat substituted by another small
RNA-guided gene regulatory mechanism, the siRNA (small interfering
RNA) pathway, which in various organisms is also capable of silencing
TE-derived mRNAs through processing endogenous double-stranded
RNA structures (Ghildiyal et al., 2008). In certain organisms, such as
plants that dispense with the Piwi-piRNA pathway, the siRNA-mediated
silencing system appears to act as the main defense mechanism against
the mobilization of TEs in both soma and germline. However, the siRNA
pathway functions less effectively than the piRNA pathway in silencing
TEs due to three factors: It (i) represses TE transcripts only when they are
processed through dsRNS intermediates, (ii) has a reduced capacity to
pack silenced TEs into heterochromatin, a tightly packed chromosomal
structure (Law & Jacobsen, 2010), and iii) does not involve a piRNA
cluster-like genomic ‘library’ system, which contains a representative
copy of each TE family, for more efficient recognition of the
corresponding TE transcripts (Aravin et al., 2007).
In the absence of active Piwi-piRNA pathway components, aging
somatic cells tend to increasingly lose heterochromatin, which normally
maintains TEs under transcriptional repression (Heyn et al., 2012; Savva
et al., 2013; Gorbunova et al., 2014; Wood et al., 2016). Thus, during
adulthood, the gradual release of TEs may generate considerable levels of
molecular damage that overwhelm the capacity of the cellular mainte-
nance and DNA repair systems, including autophagy, the ubiquitin–
proteasome system, molecular chaperones, and the distinct DNA repair
pathways (Fig. 2). The affected cell may become compromised, and then
Fig. 1 A possible correlation between mortality and mutation rates in humans
and hydra. In the potentially immortal freshwater hydra, in which the Piwi-piRNA
pathway is active both somatically and in the germline, inhibiting TE activity
essentially in the whole body, a risk of acquiring a fatal disease does not increase
with age (the horizontal green line). In this organism, metabolic (e.g. reactive
oxygen species), environmental (e.g. high temperatures), and genetic
(spontaneous mutations from DNA replication inaccuracy and mutations induced
by chemical/physical agents) factors generate cellular damage at a nearly constant
rate (the horizontal dashed gray line). Damaged cytoplasmic constituents produced
this way can be effectively eliminated by repair/maintenance (cell cleaning)
systems. Rarely, when the elimination is unsuccessful, the affected cells become
lost, thereby maintaining the functionality of the somatic tissue. In humans,
however, in addition to these mutagenic and damaging factors, TEs generate
damaged (mutant) intracellular proteins at an increasing rate in somatic cells
throughout the lifespan (dotted gray curve). In these cells, the Piwi-piRNA pathway
is largely inactive, which allows self-replicating TEs to accumulate exponentially.
When the level of damages passes a critical threshold, the (saturated) repair/
maintenance systems cannot eliminate all of them, leading to a significant amount
of cell death. As a consequence, an age-associated fatal disease can develop,
leading to mortality along an exponential rate (red curve). Thus, the exponential
mortality rate in humans could be correlated with the exponential mutational rate
caused by TEs.
Transposable elements and aging, A. Sturm et al. 907
ª 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
eliminated via cell death to ensure the functional integrity of the somatic
tissue. The repair andmaintenance (cell cleaning)mechanisms are likely to
be equally effective in the soma and germline in eliminating damages
produced by metabolic (e.g. reactive oxygen species) and environmental
(e.g. heat orUV radiation) factors, aswell as those causedby transposition-
independent mutations (i.e. induced by chemical and physical mutagens,
or resulting from replication inaccuracy) that occur at a nearly constant
rate throughout the lifespan (Fig. 2). In addition to their increasing
mobilization during adult life, TEs can inactivate genes that function in the
repair and maintenance systems, further contributing to the age-
associated accumulation of cellular damage. Unrepaired cellular damage
can frequently cause cell loss. Elevated levels of cell deathmay then trigger
tissue deterioration associated with an age-related pathology, and,
eventually, organismal death. In contrast, the Piwi-piRNA pathway
protects the germline and nonaging somatic cells from TE-mediated
mutagenesis. Occasional mutations generated by chemical and physical
mutagens are effectively recognized and eliminated by cellular mainte-
nance and repairmechanisms, and if not, the affected cell is removed from
the tissue via cell death (Vellai, 2009; Vellai et al., 2009; Vellai & Takacs-
Vellai, 2010). Therefore, nonaging cells (tissues) are potentially immortal
as their genomes remain largely intact and stable. In otherwords, the Piwi-
piRNA pathwaymay play a critical role in cellular immortality, and TEs may
represent the primary genetic determinants of aging (Sturm et al., 2015)
(Fig. 2).
Alternatively, the Piwi-piRNA pathway may have a different, TE-
independent, but as of yet unexplored function to ensure genomic
integrity in nonaging cells. For example, the pathway may regulate the
transcription of certain key genes via modulating chromatin
Fig. 2 A model of aging driven by transposable element activity. Aging is driven by the progressive, lifelong accumulation of unrepaired cellular damage. Such damages
mainly include oxidized, aggregated, or misfolded (nonfunctional) proteins that can act as cellular toxins, thereby compromising cell function and viability. Damage can be
produced by injurious exogenous and endogenous factors such as high temperatures and reactive oxygen species, or by mutations generated spontaneously (from
replication error) or caused by chemical and physical mutagens. These damages are incurred at a nearly constant level in both soma and germline throughout the adult
lifespan, and can be effectively repaired or eliminated at the DNA or protein level by the repair/maintenance systems, including the distinct DNA repair pathways, autophagy
(the main mechanism of cellular self-degradation), the proteasome–ubiquitin system, and molecular chaperones. Occasionally, if repair/degradation fails, the compromised
cell is rapidly lost via cell death, thus maintaining the integrity of the tissue. In aging somatic cells, however, in which the Piwi-piRNA pathway is not active, the mobilization
of TEs (biological mutagens) generates additional mutations at an increasing rate throughout the adult lifespan, thereby causing severe genomic instability at advanced ages.
The TE-induced mutations remain unrepaired, and lead to further protein damages that increasingly accumulate in the cytoplasm. Under a critical threshold, TE-derived
damages are also eliminated by the maintenance systems. When the level of TE-triggered cellular damages passes this threshold, the affected cell initiates a self-killing
program. Massive levels of cell death then cause a fatal age-associated disease, and, eventually, death. The mobilization of TEs can mutagenize genes that participate in
repair and maintenance systems. For example, when a TE jumps into an autophagy-related gene in an individual somatic genome, the autophagic process becomes
compromised in the affected cell. This mechanism can explain why the capacity of the repair and maintenance systems declines in old organisms, which further contributes
to the accumulation of cellular damage in this life period. Thus, TE-caused genomic instability predominantly contributes to the aging process. In other words, TEs may
represent the primary genetic determinants of aging. Thick arrows represent significant effects, while thin ones show slight effects. Within the thick arrows at right: AAP,
age-associated pathology; D, death.
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organization. It is also possible that besides the Piwi-piRNA system,
another molecular mechanism operates in nonaging cells to preserve the
stability of their genomes. Such a mechanism however has not yet been
identified. Nevertheless, the activity of the Piwi-piRNA pathway is a
shared feature of all nonaging cells identified so far.
As shown recently in Drosophila, the mobilization of TEs gradually
increases in the brain during aging (Li et al., 2013). However, the cause-or-
consequence context behind this phenomenon remains unresolved.
Whether the aging of the animal is a result of growing TE mobilization,
or TEs progressivelymobilize because the animal ages, is an issue that these
observations cannot address. To unequivocally answer this problem one
should simultaneously block themembers of an active TE family anddetect
lifespan extension in the treated organisms. Several other indications for
the associationof TE activitywith senescencewere reported in theprevious
years. For example, in yeast, TEs are highly active in agingmother cells, the
genetic integrity ofwhich is severely compromised (Pattersonet al., 2015).
In the Drosophila fat body, TEs become derepressed in an age-dependent
manner, and their mobilization is accompanied by the deterioration of the
organ and elevated levels of DNA damage (Chen et al., 2016). Consistent
with these results, the expression of TEs in this organism also progressively
increases in neurons, and the suppression of age-associated TE activation
promotes longevity (Wood et al., 2016). Moreover, studies on mice have
shown that TEs are gradually mobilized and multiplied in different tissues
over the adult lifespan,most obviously in thebrain (DeCeccoet al., 2013b;
Van Meter et al., 2014).
When a novel TE-like sequence invades a eukaryotic genome, for
instance following a retroviral infection, a copy of the new DNA stretch
may be transferred into a specific genomic locus called the piRNA cluster.
This particular part of the host genome actually collects single copies of
all TE families, thereby serving as a ‘genomic memory’ or immune pool
to distinguish endogenous (‘self’) DNA sequences, which emerged
within the lineage, from foreign (‘nonself’) ones, which emerged from
outside the lineage. This acquired immunity-like genetic system is likely
to have evolved for genome maintenance by suppressing deleterious TE
activity analogous to that of the CRISPR/Cas (clustered regularly
interspaced short palindromic repeats/CRISPR-associated nuclease sys-
tem) mechanism, which protects bacterial cells from the effect of
infective foreign phages or plasmid DNA. For example, when a phage
first infects a bacterial species, a copy of its DNA fragment is inserted
into the CRISPR array of the host genome as a novel spacer sequence,
which then confers to it a resistance against the same viral DNA (Koonin,
2017). As with short segments of spacer DNA within the CRISPR array,
piRNA genes code for transcripts that mediate the sequence-specific
recognition and subsequent degradation of the corresponding TE
mRNAs by Piwi family proteins.
Why does a large fraction of eukaryotic genomes encode TEs if
these repetitive elements are so mutagenic? We hypothesize that TEs
may have a dual role in lifespan determination as, besides perturbing
the function of somatic cells through harmful insertional mutations
they generate, they can also protect somatic tissues from undergoing
tumorigenesis. In other words, TEs can be used as a ‘tool’ for increasing
longevity as they can delay organismal death through providing a
protection against cancer. Compared with nondividing cells, the faster
metabolic rate of tumorous cells is associated with elevated transcrip-
tional activity mediated by chromatin opening, which also allows TE
mobilization, leading to genome instability and eventually cell loss. TEs
therefore may function as a ‘time bomb’, the ‘ticking’ of which is much
faster in hyperproliferating cells than in nondividing cells. Indeed,
numerous recent studies have shown that cancerous cells display
ectopic expression of Piwi proteins and Piwi-interacting RNAs, and
these factors exert transcriptional and posttranscriptional gene regula-
tory actions (Siddiqi et al., 2012; Hashim et al., 2014; Ross et al.,
2014). Immortal HeLa cells also abundantly accumulate Piwi proteins
and express piRNAs (Lu et al., 2010). Furthermore, the oncogenic
transformation of somatic cells induces a functional piRNA pathway
(Fagegaltier et al., 2016). Consistent with these data, ectopic expres-
sion of Piwi proteins in the soma can initiate tumor growth (Janic et al.,
2010; Siddiqi et al., 2012). Thus, genes acting in the Piwi-piRNA
pathway function as proto-oncogenes, and their products serve as
potent tumor markers (Tan et al., 2015). Together, these data imply
that a nascent tumor can be stabilized when hyperproliferating cancer
stem cells stabilize their genetic integrity via TE repression combined
with telomere maintenance. Therefore, tumor cells adopt germline-
specific characteristics, including the ectopic expression of Piwi proteins
and piRNAs. As a supporting evidence, in Drosophila, mutation-
triggered brain tumors are characterized by the ectopic expression of
germline-specific genes including vasa, piwi, aubergine, and ago3,
many of which code for proteins in the Piwi-piRNA pathway (Janic
et al., 2010). In addition, many of the small regulatory RNAs (such as
mi- and piRNAs) that accumulate at high levels in brain tumors are also
highly expressed in the normal ovary. Tumor cells thus reanimate
multiple germ cell features (Wu & Ruvkun, 2010).
As the germline is largely free of TE activity due to a functional
consequence of the Piwi-piRNA pathway, this cell type should be more
sensitive to tumorigenesis than those lacking the pathway. Indeed, in the
nematode Caenorhabditis elegans, the only tissue in which a tumor
could be induced is the germline (Kirienko et al., 2010). In humans, 95%
of testicular cancer is likewise germline-based (Ye & Ulbright, 2012).
Another possible reason for the widespread existence of TEs in
eukaryotic genomes may stem from evolutionary benefits: by leading
to the elimination of old, postreproductive individuals from the popu-
lations, TEs may significantly lower intraspecific competition under
conditions of limited resources. Alternatively, TEs may serve to increase
genetic diversity through mediating genomic rearrangements.
Finally, if further research indeed pinpoints TE-mediated insertional
mutagenesis as the primary genetic determinant of aging, the question
of why genetic analysis has failed to reveal this important function of
jumping genes for so long will have to be answered. Forward and
reverse genetic approaches rely on the phenotypic characterization of
single-gene mutations and knockdowns. However, TEs are generally
present in large copy numbers in eukaryotic genomes. As an example,
the human genome encodes around 870 000 LINE (long interspersed
nuclear element) and 1 560 000 SINE (short interspersed nuclear
element) retrotransposons (Lander et al., 2001). Although only a
fraction of these elements is transpositionally active, it has been
estimated that the diploid human genome contains >100 transposi-
tionally active LINE-1 elements (Brouha et al., 2003), thousands of
active copies of the Alu retrotransposon (Hormozdiari et al., 2011) and
~1000 potentially active copies of the composite retrotransposon SVA
(Hancks & Kazazian, 2010). Therefore, it appears to be almost
impossible to completely inactivate a certain TE family by inducing
mutations in each active member of the family. Gene silencing also
becomes ineffective over a defined number of paralogous genes
targeted for downregulation. In addition, the contribution of a single
TE family to the whole lifespan phenotype is likely to be rather
moderate and hence difficult to detect as numerous TE families
constitute the repetitive fraction of eukaryotic genomes. Considering
these facts, to provide direct evidence that the progressive, lifelong
mobilization of TEs represents the primary mechanism of aging will
certainly not be an easy task.
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